Cited by 2,309Tuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisMycobacterium research and diagnosis

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

Open access

Boehme, Catharina C., Nabeta, Pamela, Hillemann, Doris, Nicol, Mark P., Shenai, Shubhada, Krapp, Fiorella, Allen, Jenny, Tahirli, Rasim, Blakemore, Robert, Rustomjee, Roxana, Milovic, Ana, Jones, Martin, O'Brien, Sean M., Persing, David H., Ruesch-Gerdes, Sabine, Gotuzzo, Eduardo, Rodrigues, Camilla, Alland, David, Perkins, Mark D.·2010·New England Journal of Medicine

DOI 10.1056/nejmoa0907847PMC PMC2947799

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Global control of tuberculosis is hampered by slow, insensitive diagnostic methods, particularly for the detection of drug-resistant forms and in patients with human immunodeficiency virus infection. Early detection is essential to reduce the death rate and interrupt transmission, but the complexity and infrastructure needs of sensitive methods limit their accessibility and effect. METHODS: We assessed the performance of Xpert MTB/RIF, an automated molecular test for Mycobacterium tuberculosis (MTB) and resistance to rifampin (RIF), with fully integrated sample processing in 1730 patients with suspected drug-sensitive or multidrug-resistant pulmonary tuberculosis. Eligible patients in Peru, Azerbaijan, South Africa, and India provided three sputum specimens each. Two specimens were processed with N-acetyl-L-cysteine and sodium hydroxide before microscopy, solid and liquid culture, and the MTB/RIF test, and one specimen was used for direct testing with microscopy and the MTB/RIF test. RESULTS: Among culture-positive patients, a single, direct MTB/RIF test identified 551 of 561 patients with smear-positive tuberculosis (98.2%) and 124 of 171 with smear-negative tuberculosis (72.5%). The test was specific in 604 of 609 patients without tuberculosis (99.2%). Among patients with smear-negative, culture-positive tuberculosis, the addition of a second MTB/RIF test increased sensitivity by 12.6 percentage points and a third by 5.1 percentage points, to a total of 90.2%. As compared with phenotypic drug-susceptibility testing, MTB/RIF testing correctly identified 200 of 205 patients (97.6%) with rifampin-resistant bacteria and 504 of 514 (98.1%) with rifampin-sensitive bacteria. Sequencing resolved all but two cases in favor of the MTB/RIF assay. CONCLUSIONS: The MTB/RIF test provided sensitive detection of tuberculosis and rifampin resistance directly from untreated sputum in less than 2 hours with minimal hands-on time. (Funded by the Foundation for Innovative New Diagnostics.)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa0907847

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,781
Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions
Agresti, A., & Coull, B. A. (1998) · The American Statistician · doi:10.1080/00031305.1998.10480550 · Cited by 3,223
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
Causland, F. R. M., Brunelli, S. M., & Waikar, S. S. (2013) · American Journal of Nephrology · doi:10.1159/000355958 · Cited by 2,705
Approximate Is Better than "Exact" for Interval Estimation of Binomial Proportions
Agresti, A., & Coull, B. A. (1998) · The American Statistician · doi:10.2307/2685469 · Cited by 980
Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914
Self-citation
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C., Glasziou, P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · PubMed · doi:10.1373/49.1.1 · Cited by 867
Requirements for high impact diagnostics in the developing world
Urdea, M. S., Penny, L., Olmsted, S. S., Giovanni, M. Y., Kaspar, P., Shepherd, A., Wilson, P. L., Dahl, C. A., Buchsbaum, S., Moeller, G., et al. (2006) · Nature · doi:10.1038/nature05448 · Cited by 589
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes
Getahun, H., Harrington, M., O’Brien, R., & Nunn, P. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60284-0 · Cited by 546

Flagged first, then by citations

Show all 26 references

Research works printed but not linked: 5

Farmer P, 1998, Int J Tuberc Lung Dis, 2, 869
Cohn ML, 1968, Am Rev Respir Dis, 98, 295
Hillemann D, 2005, Int J Tuberc Lung Dis, 9, 1409
Yagui M, 2006, Int J Tuberc Lung Dis, 10, 838
Urbanczik R, 2009, Int J Tuberc Lung Dis, 13, 799

Sorted by citations

Items 701–800 of 1,000

Tuberculosis in prisons in sub-Saharan Africa – a potential time bomb
O’Grady, J., Mwaba, P., Bates, M., Kapata, N., & Zumla, A. I. (2011) · South African Medical Journal · doi:10.7196/samj.4629 · Cited by 29
Robust, reliable and resilient: designing molecular tuberculosis tests for microscopy centers in developing countries
Denkinger, C. M., Kik, S. V., & Pai, M. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.850034 · Cited by 29
Population-Level Impact of Same-Day Microscopy and Xpert MTB/RIF for Tuberculosis Diagnosis in Africa
Dowdy, D. W., Davis, J. L., den Boon, S., Walter, N. D., Katamba, A., & Cattamanchi, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070485 · Cited by 31
Countrywide roll-out of Xpert ® MTB/RIF in Swaziland: the first three years of implementation
Sikhondze, W., Dlamini, T., Khumalo, D., Maphalala, G. P., Dlamini, S., Zikalala, T., Albert, H., Wambugu, J., Tayler‐Smith, K., Ali, E., et al. (2015) · Public Health Action · doi:10.5588/pha.15.0001 · Cited by 28
The future of molecular diagnostics for drug-resistant tuberculosis
Heysell, S. K., & Houpt, E. R. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.25 · Cited by 28
High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China
Wang, T., Feng, G., Pang, Y., Liu, J., Zhou, Y., Yang, Y., Dai, W., Zhang, L., Li, Q., Gao, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep25251 · Cited by 27
Screening for Tuberculosis With Xpert MTB/RIF Assay Versus Fluorescent Microscopy Among Adults Newly Diagnosed With Human Immunodeficiency Virus in Rural Malawi: A Cluster Randomized Trial (Chepetsa)
Ngwira, L. G., Corbett, E. L., Khundi, M., Barnes, G. L., Nkhoma, A., Murowa, M., Cohn, S. E., Moulton, L. H., Chaisson, R. E., & Dowdy, D. W. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy590 · Cited by 28
High Prevalence of Tuberculosis and Serious Bloodstream Infections in Ambulatory Individuals Presenting for Antiretroviral Therapy in Malawi
Bedell, R., Anderson, S. T. B., van Lettow, M., Åkesson, A., Corbett, E. L., Kumwenda, M., Chan, A. K., Heyderman, R. S., Zachariah, R., Harries, A. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039347 · Cited by 28
Current Approaches to Tuberculosis in the United States
Gordin, F. M., & Masur, H. (2012) · JAMA · doi:10.1001/jama.2012.7505 · Cited by 28
Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential
Beal, S. G., Assarzadegan, N., & Rand, K. H. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1134325 · Cited by 28
Extensively Drug-Resistant Tuberculosis
Wilson, J. W., & Tsukayama, D. T. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.01.014 · Cited by 29
The Influence of HIV on the Evolution of Mycobacterium tuberculosis
Koch, A. S., Brites, D., Stucki, D., Evans, J. C., Seldon, R., Heekes, A., Mulder, N., Nicol, M. P., Oni, T., Mizrahi, V., et al. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx107 · Cited by 30
Self-citation
A single-tube approach for in vitro diagnostics using diatomaceous earth and optical sensor
Zhao, F., Koo, B., Liu, H., Jin, C. E., & Shin, Y. M. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.08.027 · Cited by 28
Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination
André, E., Isaacs, C., Affolabi, D., Alagna, R., Brockmann, D., de Jong, B. C., Cambau, E., Churchyard, G., Cohen, T., Delmée, M., et al. (2016) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.16.0015 · Cited by 27
Self-citation
Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program
Clouse, K., Blevins, M. L., Lindegren, M. L., Yotebieng, M., Nguyen, D. T., Omondi, A., Michael, D., Zannou, D. M., Carriquiry, G., & Pettit, A. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171384 · Cited by 27
Impact of involvement of non-formal health providers on TB case notification among migrant slum-dwelling populations in Odisha, India
Dutta, A., Pattanaik, S., Choudhury, R., Nanda, P., Sahu, S., Panigrahi, R., Padhi, B. K., Sahoo, K. C., Mishra, P. R., Panigrahi, P., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196067 · Cited by 27
Tuberculosis: a focused review for the emergency medicine clinician
Long, B., Liang, S. Y., Koyfman, A., & Gottlieb, M. A. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.12.040 · Cited by 27
Cost-effectiveness analysis of Xpert in detecting Mycobacterium tuberculosis: A systematic review
Hao, X., Lou, H., Bai, J., Ding, Y., Yang, J., & Pan, W. H. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.078 · Cited by 27
Multicentric validation of indigenous molecular test Truenat™ MTB for detection of Mycobacterium tuberculosis in sputum samples from presumptive pulmonary tuberculosis patients in comparison with reference standards
Gomathi, N. S., Singh, M., Singh, U. B., Myneedu, V. P., Chauhan, D. S., Sarin, R., Mohan, A., Bhatnagar, A. K., Khangembam, J. S., Thiruvengadam, K., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2539_19 · Cited by 27
The potential impact of new diagnostic tests on tuberculosis epidemics.
Dye, C. (2012) · Europe PMC (PubMed Central) · Cited by 27
Utility of propidium monoazide viability assay as a biomarker for a tuberculosis disease
Nikolayevskyy, V., Miotto, P., Pimkina, E., Balabanova, Y., Kontsevaya, I., Ignatyeva, O. A., Ambrosi, A., Šķenders, Ģ., Ambrozaitis, A., Kovalyov, A. M., et al. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.11.005 · Cited by 27
Performance of Cepheid® Xpert MTB/RIF® and TB-Biochip® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis
Kurbatova, E. V., Kaminski, D. A., Ерохин, В. В., Volchenkov, G. V., Andreevskaya, S. N., Черноусова, Л. Н., Demikhova, O. V., Ershova, J. V., Kaunetis, N. V., Kuznetsova, T. A., et al. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1798-0 · Cited by 27
Factors associated with delayed tuberculosis diagnosis in China
Meyssonnier, V., Li, X., Shen, X., Wang, H., Li, D. Y., Liu, Z. M., Liu, G., Mei, J. V., & Gao, Q. (2012) · European Journal of Public Health · doi:10.1093/eurpub/cks037 · Cited by 27
Molecular Diagnosis of TB in the HIV Positive Population
Vittor, A. Y., Garland, J. M., & Gilman, R. H. (2015) · Annals of Global Health · doi:10.1016/j.aogh.2015.01.001 · Cited by 28
Can a Simple Flotation Method Lower the Limit of Detection of Mycobacterium tuberculosis in Extrapulmonary Samples Analyzed by the GeneXpert MTB/RIF Assay?
Taylor, N., Gaur, R. L., Baron, E. J., & Banaei, N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01012-12 · Cited by 27
Evaluation of the modified colorimetric resazurin microtiter plate-based antibacterial assay for rapid and reliable tuberculosis drug susceptibility testing
Katawera, V., Siedner, M. J., & Boum, Y. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0259-6 · Cited by 28
Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine
De, P., Amin, A. G., Valli, E., Perkins, M. D., McNeil, M., & Chatterjee, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144088 · Cited by 27
Self-citation
Identification of antibiotics in wastewater: current state of extraction protocol and future perspectives
Faleye, A. C., Adegoke, A. A., Ramluckan, K., Bux, F., & Stenström, T. A. (2017) · Journal of Water and Health · doi:10.2166/wh.2017.097 · Cited by 27
GeneXpert MTB/RIF for rapid diagnosis and rifampin resistance detection of endobronchial tuberculosis
Zhang, Q., Zhang, Q., Sun, B., Liu, C., Su, A., Wang, X., Liu, N., Zhang, J., Kang, J., & Hou, G. (2018) · Respirology · doi:10.1111/resp.13316 · Cited by 27
Genomic prediction of tuberculosis drug-resistance: benchmarking existing databases and prediction algorithms
Ngo, T.-M., & Teo, Y. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2658-z · Cited by 27
Pharmacologic management of Mycobacterium ulcerans infection
van der Werf, T. S., Barogui, Y. T., Converse, P. J., Phillips, R. O., & Stienstra, Y. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1752663 · Cited by 27
Evidence for Tuberculosis in Individuals With Xpert Ultra “Trace” Sputum During Screening of High-Burden Communities
Sung, J., Nantale, M., Nalutaaya, A., Biché, P., Mukiibi, J., Kamoga, C. E., Akampurira, J., Kayondo, F., Kiyonga, R., Mukiibi, M., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad595 · Cited by 27
Bronchoscopy in suspected pulmonary TB with negative induced-sputum smear and MTD® Gen-probe testing
Iyer, V., Joshi, A. Y., Boyce, T. G., Brutinel, M., Scalcini, M., Wilson, J. W., McCoy, K., & Aksamit, T. R. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.03.003 · Cited by 26
Diagnosis of Mycobacterium tuberculosis using molecular biology technology
Garberi, J. E., Labrador, J., Garberi, F., Garberi, J. E., Peneipil, J., Garberi, M., Scigliano, L., & Troncoso, A. (2011) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(11)60002-6 · Cited by 26
The Urgent Need for New Diagnostics for Symptomatic Tuberculosis in Children
Cuevas, L. E. (2010) · The Indian Journal of Pediatrics · doi:10.1007/s12098-010-0354-0 · Cited by 26
An Automated Screening System for Tuberculosis
Mozos, R. S., Pérez‐Cruz, F., Madden, M. G., & Artés-Rodrı́guez, A. (2013) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2013.2282874 · Cited by 26
Evaluating the diagnostic accuracy of the Xpert MTB/RIF assay on bronchoalveolar lavage fluid: A retrospective study
Lu, Y., Zhu, Y., Shen, N., Tian, L., & Sun, Z. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.01.030 · Cited by 26
Rapid molecular test for tuberculosis: impact of its routine use at a referral hospital
Casela, M., Cerqueira, S. M. A., Casela, T. D. O., Araújo‐Pereira, M., dos Santos, S. Q., del Pozo, F. A., Freire, S. M., & Matos, E. D. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000201 · Cited by 26
Lab-on-a-Film disposable for genotyping multidrug-resistant Mycobacterium tuberculosis from sputum extracts
Kukhtin, A., Sebastian, T., Golova, J. B., Perov, A., Knickerbocker, C., Linger, Y., Bueno, A., Qu, P., Villanueva, M., Holmberg, R. C., et al. (2019) · Lab on a Chip · doi:10.1039/c8lc01404c · Cited by 26
Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia
Kebede, A., Beyene, D., Yenew, B., Diriba, G., Mehamd, Z., Alemu, A., Amare, M., & Ameni, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225205 · Cited by 26
Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018
Safaev, K., Parpieva, N., Ливерко, И. В., Yuldashev, S., Dumchev, K. V., Gadoev, J., Korotych, O., & Harries, A. D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094663 · Cited by 26
EasyNAT MTC assay: A simple, rapid, and low-cost cross-priming amplification method for the detection of mycobacterium tuberculosis suitable for point-of-care testing
Zhang, Z., Du, J., Liu, T., Wang, F., Jia, J., Dong, L., Zhao, L., Xue, Y., Jiang, G., Yu, X., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1959271 · Cited by 26
Resistance profiles and rpoB gene mutations of Mycobacterium tuberculosis isolates in Taiwan
Lin, Y., Tai, C.-H., Li, C.-R., Lin, C.-F., & Shi, Z. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.06.008 · Cited by 26
Tuberculosis of the eye in Italy: a forgotten extrapulmonary localization
Tognon, M. S., Fiscon, M., Mirabelli, P., Graziani, G., Peracchi, M., Sattin, A., Marinello, S., Vianello, F., & Sgarabotto, D. (2013) · Infection · doi:10.1007/s15010-013-0554-4 · Cited by 26
The Application of GeneXpert MTB/RIF for Smear-Negative TB Diagnosis as a Fee-Paying Service at a South Asian General Hospital
Shrestha, P., Arjyal, A., Caws, M., Prajapati, K. G., Karkey, A., Dongol, S., Mahat, S. P., Prajapati, S., & Basnyat, B. (2015) · Tuberculosis Research and Treatment · doi:10.1155/2015/102430 · Cited by 26
Integrating the Xpert MTB/RIF Assay into a Diagnostic Workflow for Rapid Detection of Mycobacterium tuberculosis in a Low-Prevalence Area
Deggim, V., Somoskövi, Á., Voit, A., Böttger, E. C., & Bloemberg, G. V. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00151-13 · Cited by 26
Molecular Beacons in Diagnostics
Tyagi, S., & Kramer, F. R. (2012) · F1000 Medicine Reports · doi:10.3410/m4-10 · Cited by 26
Microsystem Technologies for Medical Applications
Cima, M. J. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114120 · Cited by 26
Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial
Bunyasi, E. W., Tameris, M. D., Geldenhuys, H. D., Schmidt, B., Luabeya, A. K. K., Mulenga, H., Scriba, T. J., Hanekom, W. A., Mahomed, H., McShane, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141623 · Cited by 26
High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, China
Maimaiti, R., Zhang, Y., Pan, K., Mijiti, P., Wubili, M., Musa, M., & Andersson, R. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-016-2152-4 · Cited by 27
Six versus 12 Months of Anti Tubercular Therapy in Patients With Biopsy Proven Spinal Tuberculosis
Nene, A., Patil, S., Kathare, A. P., Nagad, P. B., Nene, A., & Kapadia, F. N. (2018) · Spine · doi:10.1097/brs.0000000000002811 · Cited by 26
Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF–identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012–2017: A Retrospective Province-Wide Cohort Study
Bulabula, A. N. H., Nelson, J. A., Musafiri, E. M., Machekano, R. N., Sam-Agudu, N. A., Diacon, A. H., Shah, M., Creswell, J., Theron, G., Warren, R. M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1105 · Cited by 26
The changing treatment landscape for MDR/XDR-TB — Can current clinical trials revolutionise and inform a brave new world?
Honeyborne, I., Lipman, M. C. I., Zumla, A. I., & McHugh, T. D. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.02.006 · Cited by 26
Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study
Najjingo, I., Muttamba, W., Kirenga, B., Nalunjogi, J., Bakesiima, R., Olweny, F., Lusiba, P., Katamba, A., Joloba, M. L., & Ssengooba, W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216901 · Cited by 26
Comparison of Lowenstein-Jensen medium and MGIT culture system for recovery of Mycobacterium tuberculosis from abscess samples
Ma, Y., Fan, J., Li, S., Dong, L., Li, Y., Wang, F., Huo, F., Pang, Y., & Qin, S. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.114969 · Cited by 27
Advances in Diagnostic Assays for TuberculosisPreprint
Lawn, S. D. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017806 · Cited by 28
Fine-needle aspiration for diagnosis of tuberculous lymphadenitis in children in Bangui, Central African Republic
Fanny, M.-L., Beyam, N., Gody, J. C., Zandanga, G., Yango, F., Manirakiza, A., Rigouts, L., Pierre-Audigier, C., Gicquel, B., & Bobossi, G. (2012) · BMC Pediatrics · doi:10.1186/1471-2431-12-191 · Cited by 25
Diagnostic accuracy of induced sputum LAM ELISA for tuberculosis diagnosis in sputum-scarce patients
Peter, J., Cashmore, T. J., Meldau, R., Theron, G., van Zyl-Smit, R. N., & Dheda, K. U. J. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0614 · Cited by 25
Cost-effectiveness analysis of the Xpert MTB/RIF assay for rapid diagnosis of suspected tuberculosis in an intermediate burden area
You, J. H. S., Lui, G. C.-Y., Kam, K. M., & Lee, N. L. S. (2015) · Journal of Infection · doi:10.1016/j.jinf.2014.12.015 · Cited by 25
Combating tuberculosis infection: A forbidding challenge
Rawal, T., & Butani, S. (2016) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.180243 · Cited by 25
Diagnosing tuberculosis in the 21st century – Dawn of a genomics revolution?
Jeanes, C., & O’Grady, J. (2016) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2016.11.028 · Cited by 25
rpoB Mutations Causing Discordant Rifampicin Susceptibility in Mycobacterium tuberculosis: Retrospective Analysis of Prevalence, Phenotypic, Genotypic, and Treatment Outcomes
Mvelase, N. R., Pillay, M., Sibanda, W., Ngozo, J., Brust, J. C. M., & Mlisana, K. P. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz065 · Cited by 25
Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients
Shi, W., Wu, J., Tan, Q., Hu, C., Zhang, X., Pan, H., Yang, Z., He, M., Yu, M., Zhang, B., et al. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s202369 · Cited by 26
Whole-genome sequencing for rapid, reliable and routine investigation of Mycobacterium tuberculosis transmission in local communities
Zakham, F., Laurent, S., Carreira, A. L. E., Corbaz, A., Bertelli, C., Masserey, É., Nicod, L. P., Greub, G., Jaton, K., Mazza‐Stalder, J., et al. (2019) · New Microbes and New Infections · doi:10.1016/j.nmni.2019.100582 · Cited by 25
Performance of conventional histopathology and GeneXpert MTB/RIF in the diagnosis of spinal tuberculosis from bone specimens: A prospective clinical study
Yu, Y., Kong, Y., Ye, J., & Wang, A. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.08.010 · Cited by 25
GC‐MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion
Liu, Y., Mei, B., Chen, D., & Cai, L. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23706 · Cited by 25
Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
Molloy, A., Harrison, J., McGrath, J. S., Owen, Z., Smith, C. A., Liu, X., Li, X., & Cox, J. A. G. (2021) · Microorganisms · doi:10.3390/microorganisms9112330 · Cited by 24
Tendência temporal da incidência de tuberculose e sua distribuição espacial em Macapá-AP
Giacomet, C. L., dos Santos, M. S., Berra, T. Z., Alves, Y. M., Alves, L. S., da Costa, F. B. P., Ramos, A. C. V., Crispim, J. D. A., Monroe, A. A., Pinto, I. C., et al. (2021) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2021055003431 · Cited by 25
The Value of GeneXpert MTB/RIF for Detection in Tuberculosis: A Bibliometrics‐Based Analysis and Review
Li, Z. (2022) · Journal of Analytical Methods in Chemistry · doi:10.1155/2022/2915018 · Cited by 25
The Small Membrane Filter Method of Microscopy to Diagnose Pulmonary Tuberculosis
Fennelly, K. P., Morais, C. G., Hadad, D. J., Vinhas, S. A., Dietze, R., & Palaci, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00572-12 · Cited by 25
A simple diagnostic aid for tuberculous meningitis in adults in Morocco by use of clinical and laboratory features
Dendane, T., Madani, N., Zekraoui, A., Belayachi, J., Abidi, K., Zeggwagh, A. A., & Abouqal, R. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.01.026 · Cited by 25
A Model of Tuberculosis Screening for Pregnant Women in Resource-Limited Settings Using Xpert MTB/RIF
Turnbull, E., Kancheya, N. G., Harris, J. B., Topp, S. M., Henostroza, G., & Reid, S. E. (2011) · Journal of Pregnancy · doi:10.1155/2012/565049 · Cited by 25
Isoniazid and Rifampicin as Therapeutic Regimen in the Current Era: A Review
Somasundaram, S., Ram, A., & Sankaranarayanan, L. (2014) · Journal of Tuberculosis Research · doi:10.4236/jtr.2014.21005 · Cited by 25
Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis
Moussa, H. S., Bayoumi, F. S., & Ali, A. M. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.10.14998 · Cited by 25
Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS
Su, K., Yan, B., Chiu, H., Yu, C., Chang, S.-Y., Jou, R., Liu, J.-L., Hsueh, P., & Yu, S. (2017) · Scientific Reports · doi:10.1038/srep41486 · Cited by 25
Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study
Hai, H., Zhang, Y., Li, S., Wang, J., Chen, J., Pan, Z., & Gan, H. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0114 · Cited by 25
Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania
Kidenya, B. R., Mshana, S. E., Fitzgerald, D. W., & Ocheretina, O. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.02.004 · Cited by 25
Automated detection of bacterial growth on 96-well plates for high-throughput drug susceptibility testing of Mycobacterium tuberculosis
Fowler, P. W., Cruz, A. L. G., Hoosdally, S., Jarrett, L., Borroni, E., Chiacchiaretta, M., Rathod, P., Lehmann, S., Molodtsov, N., Walker, T. M., et al. (2018) · Microbiology · doi:10.1099/mic.0.000733 · Cited by 25
Head-to-head comparison of the diagnostic accuracy of Xpert MTB/RIF and Xpert MTB/RIF Ultra for tuberculosis: a meta-analysis
Jiang, J., Yang, J., Shi, Y., Jin, Y., Tang, S., Zhang, N., Lu, Y., & Sun, G. (2020) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2020.1788222 · Cited by 25
Diagnostic accuracy and effectiveness of the Xpert MTB/RIF assay for the diagnosis of HIV-associated lymph node tuberculosis
Van Rie, A., Page-Shipp, L., Mellet, K., Scott, L., Mkhwnazi, M., Jong, E., Omar, T., Beylis, N., Stevens, W., Sanne, I., et al. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1890-0 · Cited by 24
Rapid detection of Mycobacterium tuberculosis in sputum using CRISPR-Cas12b combined with cross-priming amplification in a single reaction
Peng, L., Fang, T., Cai, Q., Li, H., Li, H. Z., Sun, H., Zhu, M., Dai, L., Shao, Y., & Cai, L. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.00923-23 · Cited by 24
Xpert MTB/RIF Ultra versus mycobacterial growth indicator tube liquid culture for detection of Mycobacterium tuberculosis in symptomatic adults: a diagnostic accuracy study
Xie, Y. L., Eichberg, C., Hapeela, N., Nakabugo, E., Anyango, I., Arora, K., Korte, J. E., Odero, R., van Heerden, J., Zemanay, W., et al. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(24)00001-6 · Cited by 24
Self-citation
Consensus Statement on Diagnostic End Points for Infant Tuberculosis Vaccine Trials
Hatherill, M., Verver, S., & Mahomed, H. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir823 · Cited by 24
Modernizing Surveillance of Antituberculosis Drug Resistance: From Special Surveys to Routine Testing
Matteo Zignol, E., van Gemert, W., Falzon, D., Jaramillo, E., Blanc, L., & Raviglione, M. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir081 · Cited by 24
Alternative Methods of Diagnosing Drug Resistance—What Can They Do for Me?
Moore, D., & Shah, N. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir448 · Cited by 24
Utility of QuantiFERON-TB Gold In-Tube assay in adult, pulmonary and extrapulmonary, active tuberculosis diagnosis
Azghay, M., Bouchaud, O., Mechai, F., Nicaise‐Roland, P., Fain, O., & Stirnemann, J. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.01.004 · Cited by 24
Rapid diagnosis of extrapulmonary tuberculosis with Xpert Mycobacterium tuberculosis/rifampicin assay
Li, Y., Pang, Y., Zhang, T., Xian, X., Wang, X., Yang, J., Wang, R., Chen, M., & Chen, W. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000522 · Cited by 24
High genetic diversity among Mycobacterium tuberculosis strains in Tehran, Iran
Azimi, T., Nasiri, M. J., Zamani, S., Hashemi, A., Goudarzi, H., Fooladi, A. A. I., Feizabadi, M. M., & Fallah, F. (2018) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2018.01.001 · Cited by 24
Nanomotion technology in combination with machine learning: a new approach for a rapid antibiotic susceptibility test for Mycobacterium tuberculosis
Vocat, A., Sturm, A., Jóźwiak, G., Cathomen, G., Świątkowski, M., Buga, R. M., Wielgoszewski, G., Cichocka, D., Greub, G., & Opota, O. (2023) · Microbes and Infection · doi:10.1016/j.micinf.2023.105151 · Cited by 24
Evaluation of Xpert MTB/RIF Ultra for the Diagnosis of Extrapulmonary Tuberculosis: A Retrospective Analysis in Saudi Arabia
Slail, M. J., Booq, R. Y., Al-Ahmad, I. H., Alharbi, A. A., Alharbi, S. F., Alotaibi, M. S. H., Aljubran, A. M., Aldossary, A. M., Memish, Z. A., Alyamani, E. J., et al. (2023) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-023-00150-z · Cited by 24
A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
Ou, X., Xia, H., Li, Q., Pang, Y., Wang, S., Zhao, B. T., Song, Y., Zhou, Y., Zheng, Y., Zhang, Z., et al. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.09.011 · Cited by 24
Self-Reported Risks for Multiple-Drug Resistance among New Tuberculosis Cases: Implications for Drug Susceptibility Screening and Treatment
Brewer, T. F., Choi, H. W., Seas, C., Krapp, F., Zamudio, C., Shah, L., Ciampi, A., Heymann, J. S., & Gotuzzo, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025861 · Cited by 24
Self-citation
International Spread of MDR TB from Tugela Ferry, South Africa
Cooke, G., Beaton, R., Lessells, R. J., John, L., Ashworth, S., Kon, O. M., Williams, O. M., Supply, P., Moodley, P., & Pym, A. S. (2011) · Emerging infectious diseases · doi:10.3201/eid1711.110291 · Cited by 24
Rapid Implementation of New TB Diagnostic Tests: Is It Too Soon for a Global Roll-Out of Xpert MTB/RIF?
Kirwan, D. E., Cárdenas, M. K., & Gilman, R. H. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0107 · Cited by 24
Assessment of diagnostic accuracy of Gene Xpert MTB/RIF in diagnosis of suspected retreatment pulmonary tuberculosis patients
Meawed, T. E., & Shaker, A. (2016) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2016.04.005 · Cited by 24
Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration
Tadesse, M., Aragaw, D., Rigouts, L., & Abebe, G. (2016) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2016.03.005 · Cited by 24
Tuberculous meningitis diagnosis and outcomes during the Xpert MTB/Rif era: a 6.5-year cohort study in Uganda
Cresswell, F. V., Bangdiwala, A. S., Bahr, N. C., Trautner, E., Nuwagira, E., Ellis, J. P., Rajasingham, R., Rhein, J., Williams, D. A., Muzoora, C. K., et al. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14610.2 · Cited by 24
Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis
Mvelase, N. R., Balakrishna, Y., Lutchminarain, K., & Mlisana, K. P. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031663 · Cited by 24
Susceptibility Test Methods: Mycobacteria, Nocardia , and Other Actinomycetes
Woods, G. L., Lin, S.-Y. G., & Desmond, E. P. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch76 · Cited by 24
Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007
Galanis, E. (2010) · Emerging infectious diseases · doi:10.3201/eid1601.090900 · Cited by 25

Authors: Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., Milovic, A., Jones, M., O'Brien, S. M., Persing, D. H., Ruesch-Gerdes, S., Gotuzzo, E., Rodrigues, C., Alland, D., & Perkins, M. D.
Affiliations: FIND (CH)
Research Center Borstel - Leibniz Lung Center (DE)
National Health Laboratory Service (ZA)
Universidad Peruana Cayetano Heredia (PE)
South African Medical Research Council (ZA)
Rutgers New Jersey Medical School (US)
Cepheid (United States) (US)
ORCID: Boehme, Catharina C.
Nabeta, Pamela
Hillemann, Doris
Nicol, Mark P.
Shenai, Shubhada
Krapp, Fiorella
Milovic, Ana
Gotuzzo, Eduardo
Rodrigues, Camilla
Alland, David
Perkins, Mark D.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2010-09-09
Volume: 363
Issue: 11
Pages: 1005-1015
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa0907847
PMC: PMC2947799
OpenAlex: W2154326381
Cited by: 2,309
References: 26
Citations by year: 2026: 72 · 2025: 92 · 2024: 70 · 2023: 68 · 2022: 99 · 2021: 128 · 2020: 119 · 2019: 136 · 2018: 154 · 2017: 169 · 2016: 154 · 2015: 176 · 2014: 184 · 2013: 195 · 2012: 226
FWCI: 140.91
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Rutgers University Community Repository (Rutgers University) (submittedVersion)
Universidad Peruana Cayetano Heredia Institutional Repository (submittedVersion, cc-by-nc-nd)
Funders: National Institute of Allergy and Infectious Diseases (R41AI052523, R01AI080653, R42AI052523, AI52523)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
Keywords: Xpert MTB/RIF, tuberculosis diagnosis, rifampicin resistance, multidrug-resistant tuberculosis, Mycobacterium tuberculosis, rapid molecular detection, sputum examination, smear-negative tuberculosis, drug susceptibility testing, HIV coinfection, Peru, Azerbaijan, South Africa, India
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Antitubercular Agents, Bacterial Proteins, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Mycobacterium tuberculosis, Prospective Studies, Reference Standards, Rifampin, DNA-Directed RNA Polymerases, Sensitivity and Specificity, Sputum, Tuberculosis, Polymerase Chain Reaction, Tuberculosis, Multidrug-Resistant, Drug Resistance, Bacterial, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks